IRTC vs JPM · rev $423.6M vs P/E 14, rev $57.35B
iRhythm Technologies Inc (IRTC) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
iRhythm Technologies Inc (IRTC) is a medical devices company listed on US.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by James Dimon.
Latest reported IRTC revenue for 2026-06-30 was $423.6M. Net income was -$14.3M. IRTC currently screens at market cap $4.55B.
Latest reported JPM revenue for 2026-06-30 was $57.35B. Net income was $21.16B. Revenue was up 15.1% from 2026-03-31 to 2026-06-30. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
IRTC currently screens at market cap $4.55B. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the IRTC and JPM stock pages for the full models.
Not investment advice.